Research

2024 Research Grant Call

Research into improvements of the cancer pathway for childhood and young adult cancers

Project Details

2024 grant call supporting research to improve the cancer pathway and quality of life for children and young adults. Funding available for projects up to 3 years, addressing treatment effectiveness, toxicity, diagnostics, and oncogenesis.

Invitation for preliminary proposal
08/01/2024

Deadline for preliminary proposal
16/02/2024 5:00 pm

Invitations for full proposals
25/03/2024

Deadline for full proposals
06/05/2024 5:00 pm

Overview

N.B. This funding round is now closed.

This is a Grant Call for research into improvements of the cancer pathway for childhood and young adult cancers. We are seeking proposals that focus on key questions in any area of cancer research which primarily addresses the needs of children and young adults with cancer and into improved quality of ongoing life.

Submitted proposals must align with the strategic objectives outlined in the research strategy.

Development of more effective treatments
Early identification and mitigation of treatment related toxicity
Identification of improved diagnostic and prognostic biomarkers
Understanding cellular and molecular oncogenesis

What can the funding be used for?

Our project grants are intended to provide funds for the employment of suitably qualified staff and the purchase of essential equipment and consumables for projects lasting up to 3 years that address the objectives outlined above. Please note that we will not contribute towards the cost of tenured posts, nor can we contribute towards institutional overheads. The maximum amount that can be applied for is up to £350,000 for applications from a single institution, or more for collaborations involving more than one institution, though most grants will be for less than this.

Who may apply?

Proposals must be submitted by a UK academic institution (university, hospital or research institute). We will consider funding international collaborations where researchers from a UK institution play a leading role. If a grant is awarded to such a collaboration, the UK institution must take overall responsibility for management of the project and must undertake to administer the funding.

Please note that we will accept no more than two proposals from a single research group.

Application process and timetable

First stage application

The first stage is a preliminary proposal which must be submitted using our online grants portal, following the link below. Preliminary proposals are reviewed by our Scientific Advisory Panel who decide which proposals to put through to the second stage.

Decisions are based on the perceived NEED of the proposed research, the potential IMPACT of the proposed research and the capacity of the research team to deliver the proposed research.

Second stage application

Second stage applications will be subject to full, external peer review to assess the scientific quality of the detailed research proposal.

Timetable

The anticipated timeline is as follows but please note that these dates may be subject to change:

Invitation for preliminary proposals: Monday 8 January 2024
Deadline for preliminary proposal: 5pm, Friday 16 February 2024
Invitations for full proposals: End of March 2024
Deadline for full proposals: Early May 2024
Awards finalised: June 2024

Registering

You can download full cost guidelines and read the full tender document relating to this call. If you have any questions relating to this grant call, please contact the Research team via email:

[email protected] More information on how to register via Flexi-Grant.

To register under this grant call, please apply here:

Apply

Contact

If you have any questions relating to this grant call,

Please contact the Research team via email:

[email protected]

Research projects we fund

Find out about the research projects we are currently funding.

Why does research give hope to children with cancer?

Q&A with Dr Srdan Rogosic

Dr Srdan Rogosic has always wanted to become a doctor. His decision to go specifically into paediatric haematology was inspired by the improved outcomes of childhood cancer survivors, which is a direct result of decades of research.